Redefining the activity of a bone-specific transcription factor: Novel insights for understanding bone formation

Journal of Bone and Mineral Research

Volumn 28, Issue 10, 2013, Pages 2060-2063

  Lian, Jane B ^a   Gordon, Jonathan A ^a   Stein, Gary S ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR RUNX2;

BONE CELL; BONE MINERALIZATION; CARTILAGE CELL; HUMAN; NONHUMAN; NOTE; OSSIFICATION; SKELETON;

ANIMALS; BONE DEVELOPMENT; CHONDROCYTES; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; OSTEOBLASTS;

EID: 84884518530     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2076     Document Type: Note

References (60)

1. Mundlos S, Otto F, Mundlos C, et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 1997; 89 (5): 773-9.
2. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89 (5): 765-71.
3. Lee B, Thirunavukkarasu K, Zhou L, et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet. 1997; 16 (3): 307-10.
4. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89 (5): 755-64.
5. Choi JY, Pratap J, Javed A, et al. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci U S.A. 2001; 98 (15): 8650-5.
6. Inada M, Yasui T, Nomura S, et al. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn. 1999; 214 (4): 279-90.
7. Ueta C, Iwamoto M, Kanatani N, et al. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J Cell Biol. 2001; 153 (1): 87-100.
8. Takeda S, Bonnamy JP, Owen MJ, Ducy P, Karsenty G., Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 2001; 15 (4): 467-81.
9. Jensen ED, Gopalakrishnan R, Westendorf JJ., Regulation of gene expression in osteoblasts. Biofactors. 2010; 36 (1): 25-32.
10. Takamoto M, Tsuji K, Yamashita T, et al. Hedgehog signaling enhances core-binding factor a1 and receptor activator of nuclear factor-kappaB ligand (RANKL) gene expression in chondrocytes. J Endocrinol. 2003; 177 (3): 413-21.
11. -/- mice by RANKL transgene. J Biol Chem. 2003; 278 (26): 23971-7.
12. Zaidi SK, Sullivan AJ, Medina R, et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO.J. 2004; 23 (4): 790-9.
13. Javed A, Bae JS, Afzal F, et al. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem. 2008; 283 (13): 8412-22.
14. Gaur T, Lengner CJ, Hovhannisyan H, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 2005; 280 (39): 33132-40.
15. Ogawa E, Maruyama M, Kagoshima H, et al. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene,the human AML1 gene. Proc Natl Acad Sci U S.A. 1993; 90 (14): 6859-63.
16. Stewart M, Terry A, Hu M, et al. Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. Proc Natl Acad Sci U S.A. 1997; 94 (16): 8646-51.
17. Takarada T, Yoneda Y., Transactivation by Runt related factor-2 of matrix metalloproteinase-13 in astrocytes. Neurosci Lett. 2009; 451 (2): 99-104.
18. Jeong JH, Jin JS, Kim HN, et al. Expression of Runx2 transcription factor in non-skeletal tissues, sperm and brain. J Cell Physiol. 2008; 217 (2): 511-7.
19. Park ES, Lind AK, Dahm-Kahler P, et al. RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries. Mol Endocrinol. 2010; 24 (4): 846-58.
20. Ardura JA, Sanz AB, Ortiz A, Esbrit P., Parathyroid hormone-related protein protects renal tubuloepithelial cells from apoptosis by activating transcription factor Runx2. Kidney Int. 2013; 83 (5): 825-34.
21. Takarada T, Hinoi E, Nakazato R, et al. An analysis of skeletal development in osteoblast- and chondrocyte-specific Runx2 knockout mice. J Bone Miner Res. 2013; 28: 2064-2069.
22. Chen H, Ghori-Javed FY, Rashid H, Serra R, Gutierrez SE, Javed A., Chondrocyte-specific regulatory activity of Runx2 is essential for survival and skeletal development. Cells Tissues Organs. 2011; 194 (2-4): 161-5.
23. Kim IS, Otto F, Zabel B, Mundlos S., Regulation of chondrocyte differentiation by Cbfa1. Mech Dev. 1999; 80 (2): 159-70.
24. Stricker S, Fundele R, Vortkamp A, Mundlos S., Role of Runx genes in chondrocyte differentiation. Dev Biol. 2002; 245 (1): 95-108.
25. Zelzer E, Glotzer DJ, Hartmann C, et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev. 2001; 106 (1-2): 97-106.
26. Liu Y, Berendsen AD, Jia S, et al. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest. 2012; 122 (9): 3101-13.
27. Li F, Lu Y, Ding M, et al. Runx2 contributes to murine Col10a1 gene regulation through direct interaction with its cis-enhancer. J Bone Miner Res. 2011; 26 (12): 2899-10.
28. Drissi MH, Li X, Sheu TJ, et al. Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J Cell Biochem. 2003; 90 (6): 1287-98.
29. Komori T., Signaling networks in RUNX2-dependent bone development. J Cell Biochem. 2011; 112 (3): 750-5.
30. Long F, Ornitz DM., Development of the endochondral skeleton. Cold Spring Harb Perspect Biol. 2013; 5 (1): a008334.
31. Nishimura R, Hata K, Matsubara T, Wakabayashi M, Yoneda T., Regulation of bone and cartilage development by network between BMP signalling and transcription factors. J Biochem. 2012; 151 (3): 247-54.
32. Shimoyama A, Wada M, Ikeda F, et al. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell. 2007; 18 (7): 2411-8.
33. Dy P, Wang W, Bhattaram P, et al. Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes. Dev Cell. 2012; 22 (3): 597-609.
34. Cheng A, Genever PG., SOX9 determines RUNX2 transactivity by directing intracellular degradation. J Bone Miner Res. 2010; 25 (12): 2680-9.
35. Yoshida CA, Komori T., Role of Runx proteins in chondrogenesis. Crit Rev Eukaryot Gene Expr. 2005; 15 (3): 243-54.
36. Liu W, Toyosawa S, Furuichi T, et al. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol. 2001; 155 (1): 157-66.
37. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P., High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol. 2002; 22 (17): 6222-33.
38. Yoshida CA, Yamamoto H, Fujita T, et al. Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev. 2004; 18 (8): 952-63.
39. Soung do Y, Dong Y, Wang Y, et al. Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation. J Bone Miner Res. 2007; 22 (8): 1260-70.
40. Kimura A, Inose H, Yano F, et al. Runx1 and Runx2 cooperate during sternal morphogenesis. Development. 2010; 137 (7): 1159-67.
41. Ducy P, Starbuck M, Priemel M, et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999; 13 (8): 1025-36.
42. Maruyama Z, Yoshida CA, Furuichi T, et al. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev Dyn. 2007; 236 (7): 1876-90.
43. Smith N, Dong Y, Lian JB, et al. Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development. J Cell Physiol. 2005; 203 (1): 133-43.
44. Xiao Z, Awad HA, Liu S, et al. Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice. Dev Biol. 2005; 283 (2): 345-56.
45. Liu JC, Lengner CJ, Gaur T, et al. Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formation. J Biol Chem. 2011; 286 (34): 30057-70.
46. Lou Y, Javed A, Hussain S, et al. A Runx2 threshold for the cleidocranial dysplasia phenotype. Hum Mol Genet. 2009; 18 (3): 556-68.
47. Hassan MQ, Javed A, Morasso MI, et al. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol. 2004; 24 (20): 9248-61.
48. Yang X, Matsuda K, Bialek P, et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell. 2004; 117 (3): 387-98.
49. Gordon JA, Hassan HQ, Saini S, et al. Pbx1 represses osteoblastogenesis by blocking Hoxa10-mediated recruitment of chromatin remodeling factors. Mol Cell Biol. 2010; 30 (14): 3531-41.
50. Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002; 108 (1): 17-29.
51. Ge C, Xiao G, Jiang D, et al. Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J Biol Chem. 2009; 284 (47): 32533-43.
52. Greenblatt MB, Shim JH, Glimcher LH., Mitogen-activated potein kinase pathways in osteoblasts. Annu Rev Cell Dev Biol. Epub. 2013 May 31. doi: 10.1146/annurev-cellbio-101512-122347
53. Zaidi SK, Young DW, Montecino M, et al. Bookmarking the genome: maintenance of epigenetic information. J Biol Chem. 2011; 286 (21): 18355-61.
54. Young DW, Hassan MQ, Yang XQ, et al. Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2. Proc Natl Acad Sci USA. 2007; 104 (9): 3189-94.
55. Lian JB, Stein GS, van Wijnen AJ, et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol. 2012; 8 (4): 212-27.
56. Ferrari N, McDonald L, Morris JS, Cameron ER, Blyth K., RUNX2 in mammary gland development and breast cancer. J Cell Physiol. 2013; 228 (6): 1137-42.
57. Jeannette T, Olga L, Irene P., Cbfa1/Runx2 expression in an ossifying basal cell carcinoma of the eyelid. Arch Dermatol Res. 2010; 302 (9): 695-700.
58. Pratap J, Wixted JJ, Gaur T, et al. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 2008; 68 (19): 7795-802.
59. Akech J, Wixted JJ, Bedard K, et al. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene. 2010; 29 (6): 811-21.
60. Sancisi V, Borettini G, Maramotti S, et al. Runx2 isoform I controls a panel of proinvasive genes driving aggressiveness of papillary thyroid carcinomas. J Clin Endocrinol Metab. 2012; 97 (10): E2006-15.